KONTA CHINA (01312): Li Qingshan appointed as Executive Director and President

22:33 17/08/2026

China Control (01312) announced that Mr. Wang Limin, the executive director and chairman of the board, has submitted his resignation as the president of the group due to internal work arrangement adjustments. However, he will continue to serve as the executive director, chairman of the board, and chairman of the company's executive committee, nomination committee, share trading committee, and investment committee. Mr. Li Qingshan has been appointed as executive director and president, as well as a member of the executive committee and share trading committee, effective from August 17, 2026.

KONTA CHINA (01312) announced that Mr. Wang Limin, Executive Director and Chairman of the Board, has submitted his resignation as the Group's President due to adjustments in internal work arrangements. However, he will continue to serve as Executive Director, Chairman of the Board, and Chairman of the Company's Executive Committee, Nomination Committee, Share Trading Committee, and Investment Committee. Mr. Li Qingshan has been appointed as Executive Director and President, as well as a member of the Executive Committee and Share Trading Committee, effective from August 17, 2026.

Meikaman De Siasun Robot & Automation (09615) will be offering shares for subscription from August 24 to August 27, planning to globally issue 23.1406 million H shares and introduce cornerstone investors such as Baillie Gifford and Tai Kang Life.

Moderna has ignited the market for mRNA cancer vaccines, and the valuations of leading stocks at low levels are expected to surge.

Xiyin-W (00625) will be offering shares for subscription from August 24 to August 27, planning to globally issue 280 million Class B shares and introducing cornerstone investors such as Tencent and Tiger Global.

Moderna has ignited the market for mRNA cancer vaccines, and the valuations of leading stocks at low levels are expected to surge.